Form4insider filings, from the source

SEC Form 4 · accession 0001645627-17-000051

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
May 1, 2017
Accepted (ET)
May 4, 2017 · 11:57 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMay 1, 2017P1,000$0.0948A20,522,949D
Common StockMay 1, 2017P1,000$0.0918A20,523,949D
Common StockMay 1, 2017P1,000$0.092A20,524,949D
Common StockMay 1, 2017P1,000$0.0895A20,525,949D
Common StockMay 1, 2017P1,000$0.085A20,526,949D
Common StockMay 1, 2017P1,000$0.085A20,527,949D
Common StockMay 1, 2017P1,000$0.086A20,528,949D
Common StockMay 1, 2017P1,000$0.085A20,529,949D
Common StockMay 1, 2017P1,000$0.083A20,530,949D
Common StockMay 1, 2017P1,000$0.082A20,531,949D
Common StockMay 1, 2017P1,000$0.082A20,532,949D
Common StockMay 1, 2017P1,000$0.082A20,533,949D
Common StockMay 1, 2017P1,000$0.083A20,534,949D
Common StockMay 1, 2017P1,000$0.0879A20,535,949D
Common StockMay 1, 2017P1,000$0.0878A20,536,949D
Common StockMay 2, 2017P1,000$0.082A20,537,949D
Common StockMay 2, 2017P1,000$0.0808A20,538,949D
Common StockMay 2, 2017P1,000$0.081A20,539,949D
Common StockMay 2, 2017P1,000$0.081A20,540,949D
Common StockMay 2, 2017P1,000$0.0807A20,541,949D
Common StockMay 2, 2017P1,000$0.081A20,542,949D
Common StockMay 2, 2017P1,000$0.081A20,543,949D
Common StockMay 2, 2017P1,000$0.081A20,544,949D
Common StockMay 2, 2017P1,000$0.081A20,545,949D
Common StockMay 2, 2017P500$0.081A20,546,449D
Common StockMay 2, 2017P500$0.081A20,546,949D
Common StockMay 2, 2017P1,000$0.0807A20,547,949D
Common StockMay 2, 2017P1,000$0.081A20,548,949D
Common StockMay 2, 2017P1,000$0.081A20,549,949D

Table II — derivative securities

No Table II lines on this filing.